Clinical Trial Update: A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting a follow-up survey comparing SERETIDE with SYMBICORT and SMART maintenance-reliever therapy in adults with moderate to s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Seretide (fluticasone propionate/salmeterol)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED